Literature DB >> 20523361

Vitreous traction and epiretinal membranes in diabetic macular oedema using spectral-domain optical coherence tomography.

A Ophir1, M R Martinez, P Mosqueda, A Trevino.   

Abstract

PURPOSE: The purpose of this study was to present an association between diabetic macular oedema (DME) and vitreoretinal interface abnormalities using 3D spectral domain optical coherence tomography (SD-OCT).
METHODS: In a retrospective study, charts and SD-OCT of consecutive patients with diffuse or focal DME were reviewed. Only one randomly chosen eye per patient with DME was included, and eyes that had another retinopathy that could affect the study analysis or that underwent vitreoretinal surgery were excluded.
RESULTS: Out of 58 eyes (58 patients) with DME, 11 eyes (19.0%) had vitreofoveal traction (Group A), either unifocally (n=6) or multifocally; that is, associated with additional extrafoveal traction site(s). Group B comprised 20 eyes (34.5%) that had sole extrafoveal vitreous traction, at either retinal and/or papillary sites. In each, the retinal oedema underlying extrafoveal traction was in continuum in at least one site with that at the central macula, as verified by the macular maps, thus presented as diffuse macular oedema. In Group C, 13 eyes (22.4%) had an epiretinal membrane (ERM), 1.5 × 3 mm to ≥6 × 6 mm in size that overlaid diffuse oedematous macula. Group D included 14 eyes (24.1%) that had neither vitreous traction nor ERM; 12 (20.7%) of them had DME secondary to leaking microaneurysms with or without leaking capillary beds, and the remaining two had leakage from non-microaneurysms sources.
CONCLUSIONS: DME was detected by the SD-OCT to be associated with sole extrafoveal vitreous traction in one-third of the patients. Further studies are required to evaluate the clinical consequences of these observations.

Entities:  

Mesh:

Year:  2010        PMID: 20523361     DOI: 10.1038/eye.2010.80

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  16 in total

1.  Quantitative assessment of macular contraction and vitreoretinal interface alterations in diabetic macular edema treated with intravitreal anti-VEGF injections.

Authors:  Ebru Nevin Cetin; Önder Demirtaş; Nihal Cesur Özbakış; Gökhan Pekel
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-06-20       Impact factor: 3.117

Review 2.  Current approaches to the management of diabetic retinopathy and diabetic macular oedema.

Authors:  Francesco Boscia
Journal:  Drugs       Date:  2010-11-12       Impact factor: 9.546

3.  Importance of 3-D image reconstruction of spectral-domain OCT on outcome of grid laser photocoagulation for diffuse diabetic macular edema.

Authors:  Avinoam Ophir; Rana Hanna; Michael R Martinez
Journal:  Int J Ophthalmol       Date:  2013-12-18       Impact factor: 1.779

4.  Extrafoveal traction in retinal vein occlusion using spectral domain optical coherence tomography.

Authors:  Michael R Martinez; Avinoam Ophir
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-04-07       Impact factor: 3.117

5.  Three-Dimensional Enhanced Imaging of Vitreoretinal Interface in Diabetic Retinopathy Using Swept-Source Optical Coherence Tomography.

Authors:  Mehreen Adhi; Emmerson Badaro; Jonathan J Liu; Martin F Kraus; Caroline R Baumal; Andre J Witkin; Joachim Hornegger; James G Fujimoto; Jay S Duker; Nadia K Waheed
Journal:  Am J Ophthalmol       Date:  2015-11-06       Impact factor: 5.258

6.  Reduced effect of anti-vascular endothelial growth factor agents on diabetics with vitreomacular interface abnormalities.

Authors:  Dan Yoon; Irene Rusu; Irene Barbazetto
Journal:  Int Ophthalmol       Date:  2013-11-22       Impact factor: 2.031

7.  The Prevalence and Distribution of Vitreoretinal Interface Abnormalities among Urban Community Population in China.

Authors:  Lei Liu; Song Yue; Jingyang Wu; Jiahua Zhang; Jie Lian; Desheng Huang; Weiping Teng; Lei Chen
Journal:  J Ophthalmol       Date:  2015-11-26       Impact factor: 1.909

8.  Strategy for the management of diabetic macular edema: the European vitreo-retinal society macular edema study.

Authors:  Ron Adelman; Aaron Parnes; Zofia Michalewska; Barbara Parolini; Claude Boscher; Didier Ducournau
Journal:  Biomed Res Int       Date:  2015-01-28       Impact factor: 3.411

9.  Vitreoretinal interface abnormalities in diabetic macular edema and effectiveness of anti-VEGF therapy: an optical coherence tomography study.

Authors:  Alexei N Kulikov; Sergei V Sosnovskii; Roman D Berezin; Dmitrii S Maltsev; Dzhambulat H Oskanov; Nikolai A Gribanov
Journal:  Clin Ophthalmol       Date:  2017-11-14

10.  Vitreoretinal interface abnormalities in patients treatedwith ranibizumab for diabetic macular oedema.

Authors:  Yun Wong; David H W Steel; Maged S Habib; Alex Stubbing-Moore; Dalvir Bajwa; Peter J Avery
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-12-12       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.